Nerve News and Research

RSS

Pilot study opens the door to a promising new therapeutic alternative for PTSD patients

PTSD, or post-traumatic stress disorder, doesn't discriminate. It affects about 15 million adults in the U.S. each year.

4 Mar 2022

Study may pave the way for better multiple sclerosis drugs

Investigators from Weill Cornell Medicine and Memorial Sloan Kettering Cancer Center have discovered how a drug for multiple sclerosis interacts with its targets, a finding that may pave the way for better treatments.

4 Mar 2022

Improvements needed in diagnosis and treatment of people with prediabetes, study says

According to the U.S. Centers for Disease Control and Prevention, prediabetes is a serious health condition in which blood sugar levels are higher than normal, but not high enough to meet the threshold for type 2 diabetes.

3 Mar 2022

Discovery provides a more precise picture of the retina's optical properties

Researchers at the National Eye Institute (NEI) have discovered that power-producing organelles in the eye's photoreceptor cells, called mitochondria, function as microlenses that help channel light to these cells' outer segments where it's converted into nerve signals.

2 Mar 2022

A ubiquitous protein may be key to the survival of neurons most impacted by glaucoma

A ubiquitous protein called sigma 1 receptor, which is known to protect cells from stress, appears key to the function and survival of the neurons most impacted by glaucoma, scientists report.

1 Mar 2022

Cow's milk protein can trigger inflammation in multiple sclerosis sufferers

Multiple sclerosis sufferers often complain of more severe disease symptoms after consuming dairy products. Researchers at the Universities of Bonn and Erlangen-Nuremberg have now found a possible cause for this.

1 Mar 2022

The stress of restaurant work is reaching a boiling point. Could a staff therapist help?

Restaurant jobs have always been difficult, but the mental stress has gotten worse during the pandemic as restaurants closed or cut hours — or became ground zero for the fight over mask-wearing.

25 Feb 2022

Pioneering technique uses a magnetic device to stimulate touch sensitive brain glial cells

Scientists at UCL have developed a new technique that uses microscopic magnetic particles to remotely activate brain cells; researchers say the discovery in rats could potentially lead to the development of a new class of non-invasive therapies for neurological disorders.

24 Feb 2022

Research reveals why a common genetic variant worsens outcomes for people with ALS and FTD

A pioneering new study led by UCL and National Institutes of Health (NIH) scientists has revealed, for the first time, why a common genetic variant worsens disease outcomes for people with the devastating adult-onset neurodegenerative diseases amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD).

24 Feb 2022

Scientists discover how a rare genetic disorder disrupts key neural interactions in the developing brain

Every time you chew, talk, yawn, or sense the zap of a toothache, cranial nerve cells are shuttling electrochemical signals to your brain.

23 Feb 2022

Researchers show how the biological system can be steered with artificial organic neurons

For the first time, researchers demonstrate an artificial organic neuron, a nerve cell, that can be integrated with a living plant and an artificial organic synapse.

23 Feb 2022

Neural mechanisms of fatigue in COVID-19 convalescents

In a recent study posted to the medRxiv* preprint server, researchers characterized the mechanisms associated with neural dysregulation in post-coronavirus disease (COVID) fatigue (pCF) by evaluating individuals recovered from mild severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection.

23 Feb 2022

‘Injections, injections, injections’: Troubling questions follow closure of sprawling pain clinic chain

On May 13 of last year, the cellphones of thousands of California residents undergoing treatment for chronic pain lit up with a terse text message: "Due to unforeseen circumstances, Lags Medical Centers will be closing effective May 19, 2021."

22 Feb 2022

Search for a treatment to stop nerve cell degeneration yields promising results

Researchers at the University of Illinois Chicago found promising results in their search for a treatment to stop nerve cell degeneration that happens in some types of disorders, such as hereditary spastic paraplegia and Parkinson's disease, which can cause significant disability.

17 Feb 2022

Twin study identifies the influence of environment and genetics in multiple sclerosis

Researchers at the University of Zurich and Munich's LMU Klinikum hospital have studied the immune system of pairs of monozygotic twins to identify the influence of the environment and of genetics in cases of multiple sclerosis.

16 Feb 2022

YME1L protein regulates the production of new nerve cells in the brain

Researchers at the University of Cologne have discovered that the protein YME1L regulates the production of new nerve cells and the maintenance of neural stem cells in the adult brain.

16 Feb 2022

Study identifies neurons that fire specifically during mathematical operations

The brain has neurons that fire specifically during certain mathematical operations. This is shown by a recent study conducted by the Universities of Tübingen and Bonn.

14 Feb 2022

Study points to vagus nerve dysfunction as a central pathophysiological feature of long COVID

New research to be presented at this year's European Congress of Clinical Microbiology and Infectious Diseases (ECCMID 2022, Lisbon, 23-26 April) suggests that many of the symptoms connected to post-COVID syndrome (PCC, also known as long COVID) could be linked to the effect of the virus on the vagus nerve – one of the most important multi-functional nerves in the body.

12 Feb 2022

Self-learning software detects peripheral arterial disease from high-resolution color fundus photography

Researchers at the University and the University Hospital of Bonn have developed a method that could be used to diagnose atherosclerosis.

12 Feb 2022

Alkem signs license agreement with Harvard to develop, commercialize new technology for treating ischemic conditions

Alkem Laboratories Limited, an Indian multinational pharmaceutical company, has signed a license agreement with Harvard University's Office of Technology Development enabling Alkem to develop and commercialize a novel technology that may help meet the dire need for effective treatment of diabetic neuropathy, foot ulcers, peripheral arterial disease (PAD), and other injuries caused by vascular disease.

11 Feb 2022

Nerve News and Research

Pilot study opens the door to a promising new therapeutic alternative for PTSD patients

Study may pave the way for better multiple sclerosis drugs

Improvements needed in diagnosis and treatment of people with prediabetes, study says

Discovery provides a more precise picture of the retina's optical properties

A ubiquitous protein may be key to the survival of neurons most impacted by glaucoma

Cow's milk protein can trigger inflammation in multiple sclerosis sufferers

The stress of restaurant work is reaching a boiling point. Could a staff therapist help?

Pioneering technique uses a magnetic device to stimulate touch sensitive brain glial cells

Research reveals why a common genetic variant worsens outcomes for people with ALS and FTD

Scientists discover how a rare genetic disorder disrupts key neural interactions in the developing brain

Researchers show how the biological system can be steered with artificial organic neurons

Neural mechanisms of fatigue in COVID-19 convalescents

‘Injections, injections, injections’: Troubling questions follow closure of sprawling pain clinic chain

Search for a treatment to stop nerve cell degeneration yields promising results

Twin study identifies the influence of environment and genetics in multiple sclerosis

YME1L protein regulates the production of new nerve cells in the brain

Study identifies neurons that fire specifically during mathematical operations

Study points to vagus nerve dysfunction as a central pathophysiological feature of long COVID

Self-learning software detects peripheral arterial disease from high-resolution color fundus photography

Alkem signs license agreement with Harvard to develop, commercialize new technology for treating ischemic conditions

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Applications Engineer

Latest News